| | |
Predicted group membership
|
---|
| | |
US
|
CS
|
C
|
CS (Validation)
|
Total
|
Original
|
Count
|
US
|
30
|
0
|
0
|
0
|
30
|
| |
CS
|
0
|
30
|
0
|
0
|
30
|
| |
C
|
0
|
0
|
30
|
0
|
30
|
| |
CS (Validation)
|
0
|
0
|
0
|
0
|
0
|
|
%
| |
100.0
|
100.0
|
100.0
|
0
|
100.0b
|
Cross-validated
|
Count
|
US
|
30
|
0
|
0
|
0
|
30
|
| |
CS
|
0
|
30
|
0
|
0
|
30
|
| |
C
|
0
|
0
|
30
|
0
|
30
|
| |
CS (Validation)
|
0
|
0
|
0
|
30a
|
30
|
|
%
| |
100.0
|
100.0
|
100.0
|
100
|
100.0c
|
- a. 30 independent samples of cracked spores of Ganoderma lucidum were used to perform validation only.
- b. 100.0% of original grouped cases were correctly classified.
- c. 100.0% of cross-validated grouped cases were correctly classified.